Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -1.56EBIT per Share
VS
Market
Sector
Industry
History
$ 4.24Close
$ 1.71 - $ 9.29 52-Week Range
Ticker Information
Ticker
LRMRCompany Name
LARIMAR THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLARIMAR THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LRMR - EBITPS Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -99.79M | $ -1.56 | 1 | 64.03M |
| 3/31/2025 | $ -95.23M | $ -1.49 | 1 | 63.96M |
| 12/31/2024 | $ -80.6M | $ -1.32 | 1 | 61.26M |
| 9/30/2024 | $ -64.77M | $ -1.02 | 1 | 63.81M |
| 6/30/2024 | $ -58.34M | $ -0.91 | 1 | 63.8M |
| 3/31/2024 | $ -45.08M | $ -0.84 | 1 | 53.55M |
| 12/31/2023 | $ -36.95M | $ -0.84 | 1 | 43.9M |
| 9/30/2023 | $ -33.38M | $ -0.76 | 1 | 43.9M |
| 6/30/2023 | $ -32.64M | $ -0.74 | 1 | 43.9M |
| 3/31/2023 | $ -32.94M | $ -0.75 | 1 | 43.9M |
Key Performance Insights, Last 5 Years
- LARIMAR THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -1.99.
- Over the past 5 years, LARIMAR THERAPEUTICS INC's average EBITPS has been $ -1.79.
- The median EBITPS for LARIMAR THERAPEUTICS INC during this period was $ -1.52
- LARIMAR THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ -0.74.
- The lowest EBITPS recorded by LARIMAR THERAPEUTICS INC in the same timeframe $ -3.57
Similar metrics to Shares WA:
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBIT per Share
[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for LARIMAR THERAPEUTICS INC is calculated as follows: EBIT [ $ -31.79M ] / (Shares WA [ 15.98M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -1.99 ] LRMR - EBIT per Share, Last 5 years
$ -3.57
Minimum
Dec 31, 2020
$ -0.74
Maximum
Jun 30, 2023
$ -1.79
Average
$ -1.52
Median
EBITPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
EBITPS in the Market:
| filtered constituents | 3.79K |
|---|---|
| min | $ -9.72 |
| max | $ 10.76 |
| average | $ 1.16 |
| median | $ 0.38 |
| std | $ 3.42 |